Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus by Brugman, Martijn H. et al.
  
 University of Groningen
Development of a diverse human T-cell repertoire despite stringent restriction of
hematopoietic clonality in the thymus
Brugman, Martijn H.; Wiekmeijer, Anna-Sophia; van Eggermond, Marja; Wolvers-Tettero,
Ingrid; Langerak, Anton W.; de Haas, Edwin F. E.; Bystrykh, Leonid V.; van Rood, Jon J.; de
Haan, Gerald; Fibbe, Willem E.
Published in:
Proceedings of the National Academy of Science of the United States of America
DOI:
10.1073/pnas.1519118112
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2015
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Brugman, M. H., Wiekmeijer, A-S., van Eggermond, M., Wolvers-Tettero, I., Langerak, A. W., de Haas, E.
F. E., ... Staal, F. J. T. (2015). Development of a diverse human T-cell repertoire despite stringent
restriction of hematopoietic clonality in the thymus. Proceedings of the National Academy of Science of the
United States of America, 112(44), E6020-E6027. https://doi.org/10.1073/pnas.1519118112
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Development of a diverse human T-cell repertoire
despite stringent restriction of hematopoietic
clonality in the thymus
Martijn H. Brugmana,1, Anna-Sophia Wiekmeijera, Marja van Eggermonda, Ingrid Wolvers-Tetterob,
Anton W. Langerakb, Edwin F. E. de Haasa, Leonid V. Bystrykhc, Jon J. van Rooda,1, Gerald de Haanc, Willem E. Fibbea,
and Frank J. T. Staala,1
aDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden 2300 RC, The Netherlands; bDepartment of
Immunology, Erasmus University Medical Center, Rotterdam 3015 CE, The Netherlands; and cDepartment of Ageing Biology and Stem Cells, European
Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Groningen 9713 AV, The Netherlands
Contributed by Jon J. van Rood, September 29, 2015 (sent for review June 23, 2015; reviewed by William J. Burlingham and John E. Dick)
The fate and numbers of hematopoietic stem cells (HSC) and their
progeny that seed the thymus constitute a fundamental question
with important clinical implications. HSC transplantation is often
complicated by limited T-cell reconstitution, especially when HSC
from umbilical cord blood are used. Attempts to improve immune
reconstitution have until now been unsuccessful, underscoring the
need for better insight into thymic reconstitution. Here we made
use of the NOD-SCID-IL-2Rγ−/− xenograft model and lentiviral cel-
lular barcoding of human HSCs to study T-cell development in the
thymus at a clonal level. Barcoded HSCs showed robust (>80%
human chimerism) and reproducible myeloid and lymphoid en-
graftment, with T cells arising 12 wk after transplantation. A very
limited number of HSC clones (<10) repopulated the xenografted
thymus, with further restriction of the number of clones during
subsequent development. Nevertheless, T-cell receptor rearrange-
ments were polyclonal and showed a diverse repertoire, demon-
strating that a multitude of T-lymphocyte clones can develop from
a single HSC clone. Our data imply that intrathymic clonal fitness is
important during T-cell development. As a consequence, immune
incompetence after HSC transplantation is not related to the trans-
plantation of limited numbers of HSC but to intrathymic events.
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Hematopoietic stem cell transplantation (HSCT) has becomecommon clinical practice in the treatment of leukemia, lym-
phoma, and certain inherited immune and metabolic disorders.
After transplantation there is an immediate need for de novo
production of granulocytes, erythrocytes, and platelets, referred
to as “hematopoietic reconstitution,” later followed by recovery of
lymphocyte numbers, termed “immune reconstitution.” Although
often successful, HSCT is associated with a number of compli-
cations arising from poor immune reconstitution, which presents
one of the most important causes of morbidity after HSCT (1, 2).
Poor myeloid reconstitution is directly linked to low numbers of
HSCs in the transplant, but the reasons for poor immune and, in
particular, T-lymphocyte reconstitution are much less clear.
A study on the application of antithymocyte globulin in cord
blood transplantation showed that antithymocyte globulin ad-
ministration in pretransplantation conditioning results in de-
creased T-cell reconstitution and survival (3), indicating the need
for a better understanding of de novo T-cell development after
HSCT. As T cells develop in the thymus, in contrast to all other
blood lineages that develop in the bone marrow (BM), HSC-
derived progenitors need to seed the thymus. Earlier work in mice
has indicated that relatively few progenitors seed the thymus (4, 5),
yet their numbers and the subsequent fate of the progeny derived
from an HSC clone has remained elusive. The nature of the thymus-
seeding cell has been subject of much debate, certainly in humans.
CD34+CD38−CD7+ cells (6, 7), CD34+CD38−CD10−CD62L+ cells
(8), and others have been proposed as thymus-seeding cells in the
human situation. In contrast to mice, the earliest human thymocytes
show a much broader lineage developmental potential, including low
levels of erythroid and megakaryocytic potential (9), and may
therefore be much closer related to HSCs or the proposed mye-
loid lymphoid precursors.
In this study, we aimed to address the functional relationship
between HSCs and developing T cells by using DNA barcoding.
This method allows marking of each stem cell and its progeny
by a unique, neutral DNA sequence that can be retrieved by next-
generation sequencing. Here we used replication-deficient lenti-
viruses to transfer a DNA barcode and the GFP into phenotypically
defined human HSCs. These marked HSCs were transplanted,
using an optimized protocol (10), into NOD/SCID/Il-2Rγ−/−
(NSG) mice (11), which allowed us to determine the dynamics of
clonal reconstitution in the thymus in great detail. We used
umbilical cord blood (UCB) as source of human stem cells, be-
cause UCB is frequently used as a readily available HSC source
with less stringent HLA (human leukocyte antigen)-matching re-
quirements (12). However, T-cell immune reconstitution, a gen-
eral problem in allogeneic HSCT, is more problematic in UCB.
Therefore, UCB provides an appropriate HSC source to address
questions of lineage tracing and clonality in the blood and immune
system. As we demonstrate here, only a fraction of HSC clones in
UCB contributes to the T-cell pool, yet a fully diverse T-cell re-
ceptor (TCR) repertoire can be generated in the thymus.
Results
We set out to better understand the functional relationship be-
tween HSCs in the BM and developing T cells in the thymus.
Significance
The number of hematopoietic stem cell clones contributing to
T-cell development is restricted at entry of and during further
development inside the thymus. However, despite this severe
restriction, a fully diverse T-cell receptor repertoire can be gen-
erated, indicating that hematological and immunological clonality
are independently regulated.
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Cellular barcoding allows this question to be addressed in a
quantitative sense. To do so, human HSC were isolated from
UCB and were transduced with a lentiviral DNA barcoding
vector that carried 485 individual barcodes (13, 14) (Fig. 1A).
We aimed to transduce <20% of the target cells to limit the
occurrence of multiple lentiviral insertions per cell. A well-
defined library with restricted complexity was used to allow full
quantification yet also to contain enough diversity to individually
track HSC, given the number of transduced HSCs per mouse. In
three independent experiments, a total of 17 mice were transplanted
with either low (26,000; n = 4) or high dose (150,000; n = 4) of
CD34+ cells or ∼1,000 highly purified HSCs (n = 9), defined as
CD34+CD38−CD45RA−CD90+CD49f+ (15).
To ensure that viral DNA barcoding methodology allows quanti-
fication of marked clones, calibration experiments were performed.
The mixtures of DNA barcodes resulting from the spike-in
experiments demonstrate a decrease of the sample from the 100%
down to the 1% spike-in sample (Fig. S1A). Linear regression
analysis showed a Pearson correlation coefficient R2 = 0.994
(Fig. S1B). In a separate experiment, nine repeat measurements
of the polyclonally transduced samples were analyzed for re-
producibility. Read fractions below 0.5% of the sample threshold
were progressively more difficult to quantify reliably as demon-
strated by the increase in coefficient of variation at lower frac-
tions of reads (Fig. S1C). Deep sequencing is prone to generate
sequence misreads at low frequency, and because our analysis is
dependent on the ability to assign and distinguish individual
barcodes, we compared all identified DNA barcodes against each
other and determined their dissimilarity.We considered barcodes with
up to two dissimilar bases to originate from the same original
barcode (Fig. S1D). Repeated measurements on CD19+ cells
isolated from peripheral blood (PB) (Fig. S1E) also demonstrated
that the method results in limited variation between samples.
Thus, the applied barcoding strategy can reliably quantify progeny
of individual HSC clones in this setting.
Transplantation of human HSC from UCB resulted in a robust
reconstitution (median 81%, range 53–92% at 16 wk) (Fig. 1B) in
all nine mice. GFP marking was initially around 20% and stabi-
lized at 16 wk at median 8.9% (range 4.5–20%) (Fig. 1C), con-
sistent with the intended low transduction rate, which limits the
occurrence of multiple integrations per cell. After 12 wk, CD3+
T cells were detectable for the first time (Fig. 1D), which coincides
with a concomitant reduction in the percentage of CD19+ B cells
(Fig. 1F), which form the majority of repopulating human cells.
Analysis of the barcodes present during repopulation demon-
strated that a limited repertoire of hematopoietic clones was re-
sponsible for the generation of myeloid cells, B cells, and T cells.
We detected a median number of 70 clones (range 51–88) per
mouse in the PB, rising to a median of 83 (range 57–107) when
BM and thymus samples with different barcodes were included.
Because the barcodes in purified HSCs are inherited by the
daughter cells, we could also investigate the contribution of the
marked clones in HSC to the B- and T-cell lineage. We therefore
analyzed the extent to which a clone retrieved from the human
HSC isolated from the NSG mice was also detected in CD19+
B cells or CD3+ T cells in the spleen. The ternary plots (Fig. 2
and Fig. S2) showed that a considerable fraction of clones was
shown to be present in two or three of these three cell types,
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Fig. 1. Barcoding human HSC and xenotransplantation. (A) Human HSC (CD34+CD38−CD45RA−CD90+CD49f+) or CD34+ cells were isolated and transduced
with the PTGZ barcode library carrying 21 variable bases in the barcode with a total complexity of 485 different barcodes. The transduced cells were
transplanted in to 5- to 6-wk-old sublethally irradiated NSG mice. The mice were bled monthly and myeloid cells, T cells, and B cells were isolated from PB. At
16 or 21 wk, the experiment was terminated and, in addition to PB, cells isolated from thymus, spleen, and BM were sorted as indicated and the barcode
content of the samples was analyzed. From the thymus, DN, DP, and SP cells were isolated using the indicated markers. Chimerism in the PB of nine mice
transplanted with 1,000 purified human HSCs as determined by human CD45 expression (B) and GFP marking of human cells (C). Development of CD3+ T cells (D),
CD13+/CD33+ myeloid cells (E), and CD19+ B cells (F) within the human CD45+ population were followed in time after transplantation of the transduced cells.



























demonstrating contribution to sorted HSC as well as the adap-
tive lymphoid lineage. This finding confirms that true HSCs with
multilineage differentiation capacity were marked by lentiviral
barcoding. The existence of myeloid, lymphoid, or mixed pro-
genitors is in line with previous reports in mice (16) and human
cells in the NSG xenograft model (17). However, none of these
studies specifically addressed the thymus or T-cell reconstitution.
To study thymic repopulation, various stages of human T-cell de-
velopment, ranging from early double-negative (DN) (CD4−CD8−)
cells to double-positive (DP) (CD4+CD8+) and single-positive
(SP) mature cells (CD4+ or CD8+) were isolated from the thymus,
as described (DN1/2: CD3−CD4−CD8−CD34+CD1a−; DN3:
CD3−CD4−CD8−CD34+CD1a+; DP: CD4+CD8+; SP: CD3+ CD8+
or CD3+ CD4+) (Fig. 3A) (18). During differentiation from poly-
clonal HSC to mature CD3+ T cells, a dramatic clonal skewing was
seen in the form of reduction of the number of clones contributing
more than 1% of the thymic populations. We used the Shannon
diversity index, a measure that can be used to describe biological
diversity (19), to capture the frequency and abundance of barcoded
clones. Using this parameter, the HSC (Fig. 3B) and high-dose
CD34+ (Fig. S3 A and C) experiments show high diversity in BM but
much lower in the thymus, with clear clonal restriction at DN1/2 and
subsequently a further restriction at the DN3 and DP stages. The
reconstitution with the 26,000 CD34+ cell dose containing lower
numbers of true HSCs led to lower diversity in BM, but still only
one clone dominates at the thymic SP or DP stage (Fig. S3 B and
D). Analysis of the DN3, DP, and SP compartments indicated a
further reduction in the number of hematopoietic clones (Fig. 3B
and Fig. S3A), but the numbers of isolated cells actually increase
going from DN1/2 through DN3 to DP, which demonstrates that
clonal restriction is not a result of smaller thymic subpopulations
investigated.
Fig. 2. Clonal contribution to HSC and adaptive immune cells. Multilineage engraftment is demonstrated by contribution of barcoded clones to HSC, splenic
CD3+ T cells and CD19+ B cells in nine NSG mice that were transplanted with purified barcoded human HSCs. The barcode content of these compartments was
determined by comparing the normalized contribution of clones. The relative contributions to the total human HSC (BM) and T- and B-lymphoid lineages
(spleen) in each mouse is shown as a ternary plot. Each point represents the contribution of a clone to HSC, CD19+ B-cell, and CD3+ T-cell lineages. The extent
of contribution is depicted by the location of the point along the three axes, with clones contributing equally to all lineages being closer to the center of the
triangle. In most mice, but especially in mouse 8 and mouse 9, true multilineage contribution of HSC clones can be observed. The numbers at the points of the
triangle indicate the number of detected clones for which contribution to only one lineage was detected.
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Fig. 3. Clonal restriction during T-cell development. Thymus was homogenized and cells were sorted into their developmental stages (DN1/2, DN3, DP,
SP) (A). The number of clones contributing >1% of the sample in nine mice transplanted with barcoded HSCs or CD34+ cells were counted and the
Shannon diversity index calculated. The normalized Shannon diversity was compared between HSC in the BM and the developmental stages in the
thymus. Mean normalized Shannon diversity indices for nine mice transplanted with 1,000 HSC are shown with error bars indicating SEM (B). Wilcoxon
P values are shown in B. (C ) Clonal repertoire, as determined by barcode analysis of sorted population in the thymus in stacked area graphs (as in A), with
colors identifying the individual clones. Note that the colors are chosen for the purpose of display, which means that the same color depicts different clones
in different mice.



























To investigate whether the restriction of clones is a result of a
limitation in the number of transplanted cells, we performed
similar experiments with 150,000 or 26,000 CD34+ cells per mouse
(containing ∼625 and ∼108 HSC, respectively) (15). Whereas
150,000 CD34+ cells are capable of generating a repopulation
pattern in the thymus similar to that observed after transplantation
of 1,000 purified HSC (Fig. S3C), transplantation of 26,000
CD34+ cells per mouse shows more limited clonal diversity, with
most compartments consisting of a few clones (Fig. S3D). Nev-
ertheless, further clonal restriction during T-cell development
was observed despite the transplantation of a sixfold higher
number of CD34+ cells, or when a 10-fold higher number of
phenotypically defined HSC was transplanted, suggesting that
thymic clonality is primarily determined by intrathymic events
rather than based on cell dose. Hence, clinically there is merit in
transplanting a higher dose of CD34+ cells to obtain a more
diverse repertoire, yet a plateau is readily reached.
Having observed the limited number of hematological clones
in the thymus, we asked the question whether this restricted
number of cells would negatively influence the TCR repertoire.
At DP and SP stages, a fully polyclonal pattern of TCRβ (TRB)
rearrangements is visible, with even further diversity in the
splenic CD3+ T cells (Fig. 4). From these data, we conclude that
a fully diverse TCR repertoire can be generated from progeny
with a high level of clonal restriction. It needs to be noted that
the polyclonality in the spleen can be interpreted as the result of
ongoing thymic output, whereas the thymic analysis is more of a
“snapshot.” Nevertheless, even at this snapshot the progeny of
HSC clones is very small, whereas thymic DP and SP cells have a
fully diverse TCR repertoire, which is further expanded in the
spleen by the accumulation of cells egressing from the thymus.
Because only a portion of the cells in the thymus and spleen were
lentivirally transduced, the untransduced cells might contribute to
this diverse repertoire; we therefore also sorted GFP+-transduced
cells from the spleen to confirm that the TCR repertoire of the
transduced cells was indeed polyclonal. This analysis demon-
strated diverse repertoires in TCRδ (TRD), TCRγ (TRG), and
TRB, thereby confirming that the limited clonal repertoire of
transduced cells does lead to the observed TRB repertoire (Fig.
S4). Our data show strong intrathymic competition between the
progeny of stem cell clones. Therefore, clonality at the HSC level
(hematological clonality) and a fully diverse TCR repertoire (im-
munological clonality) are independently regulated.
Discussion
The relationship between hematopoietic stem cells and T cells in
quantitative terms previously was largely unexplored. Previous
studies in mice showed that a limited number of HSC can be
marked, transplanted, and identified this way. Initially, such
studies were performed using the unique marks that virus insertion
form when they integrate into the host genome (20, 21). From
these studies, several models for behavior of the hematopoietic
system were postulated and mathematically modeled (22). DNA
barcoding technology allowed a much more refined insight into
the composition of the blood compartments and allowed the study
of aging HSC (13) and distribution of HSC clones through the
different locations in the body (14), in addition to the clonal dy-
namics of repopulation of the BM subset hierarchy after trans-
plantation (23, 24). The existence of myeloid, lymphoid, or mixed
progenitors, which had previously been observed in mice (16), was
demonstrated with human cells in the NSG xenograft model (17),
and although these seminal studies in the xenograft system dem-
onstrated the dynamics of lymphoid development, they did not
address T-cell development nor thymic function.
Using lentiviral cellular barcoding of purified human HSCs or
CD34+ progenitor cells, we here show at least 10% of the HSC
clones are GFP-marked in the thymus (Fig. S5) and show con-
siderable barcode-defined clonal restriction. How this restriction
in clonal repertoire in the thymus occurs is not yet understood. It
is conceivable that competition of DN cells for thymic niches
(specific location in the thymus that need to be reached for
further development), fitness of the individual clone for pro-
gression in development, or stochastic events drive competition
between clones.
Intrathymic events that regulate TCR repertoire and the in-
tegrity and quality of thymic epithelial cells are likely an important
factor. As a consequence, efforts to improve thymic reconstitution
using cytokines [IL7 (25), SCF, KFG (26, 27), FLT3L (28)] or
hormones [growth hormone (29), thyroid-stimulating hormone
(30), and ablation of sex hormones (31)] are only likely to be ef-
fective if they selectively act on the thymic microenvironment or
mimic signals given by the thymic epithelial cells to developing
thymocytes. Transplantation of committed T-cell progenitors to-
gether with HSCT, as shown before with mouse hematopoietic
cells cultured ex vivo on OP9-DL1 expressing stromal support—
which provide the cells with the Notch signals required to direct
T-cell development (32)—as well as diminishing the influence of
male sex hormones known to deregulate intrathymic Notch ligand
DLL4 (31) may work well to improve thymic function and support
diverse TCR repertoire formation. There is one interesting phys-
iological situation in which hematopoietic reconstitution can be
stimulated: namely, by exposure to noninherited maternal anti-
gens of the HLA-locus (33). This phenomenon is now widely
recognized in UCB transplantations and indicates that effective
T-cell responses can be mounted with beneficial (e.g., graft vs.
leukemia) effects (34, 35). Although such exposure would theo-
retically lead to increased thymic output, the effect on TCR
repertoire is expected to be limited; hence efforts directed at
increasing overall thymic output are warranted.
Xenotransplantation of human cells in mice is a valuable ap-
proximation of the normal development of human cells. In NSG
mice, the human cells develop into mature functional T cells that
are responsive to immunization (10, 36) and the thymus shows
highly similar phenotype to normal human thymi (37). Compared
with human control samples (Fig. S6), xenotransplanted NSG
mice show lower CD3+ cell counts (Wilcoxon test, P = 0.0015),
Fig. 4. Separation of hematological and immunological clonality. TRB repertoires in DP and SP thymic subsets, and sorted CD3 splenocytes of mice trans-
planted with human HSC were determined. Electropherograms of two collections of primers amplifying the TRB locus (green and blue) show the TRB diversity
for a representative mouse. The positive control shows peripheral blood mononuclear cells (PBMC) of a healthy individual.
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but within the CD3+ cells, the percentage of CD4 and CD8 T cells
is comparable. Furthermore, human and xenografted CD8 T cells
show similar distribution of CD45RA+ naive cells and CD45RO+
memory cells, but CD4 CD45RO+ memory T cells are present in
a significantly higher proportion in the transplanted NSG mice
(P = 0.009), which might point to ongoing homeostatic prolifer-
ation in the CD4 compartment. Analysis of the interaction be-
tween murine thymic stroma and human T cells showed that T
cells are capable of migrating to the site where they are expected
to reside, corresponding to their developmental stage in mouse thy-
mus in response to murine Ccl25, Cxcl12, and Ccl21, all chemokines
that attract T cells to the thymus (38). Several papers have
addressed the TCR repertoire in NSG mice in the presence or
absence of transgenic human HLA-A2. First, Shultz et al. (39) dem-
onstrated a functional Epstein–Barr virus infection in xenografted
NSG mice and compared the responses of xenografted NSG or
NSG with transgenic expression of HLA-A2. No differences
were observed in the frequency of naive, central memory and
effector-memory CD8 T cells in the spleen or for Granzyme A
and B or Perforin expression. The only demonstrable difference
between NSG and HLA-A2-expressing NSG is seen in response
to HLA-A2 restricted BMLF and LMP1 proteins. Second, the
issue of interaction of the xenografted cells with transgenic hu-
man HLA-A2 was elegantly addressed by Halkias et al. (40),
where HLA-A2 transgenic NSG were compared with normal
NSG after transplantation of HLA-A2+ or HLA-A2− human
UCB cells. No differences were observed in repopulation and T
cells in the spleen. Thus, the reported findings on T-cell devel-
opment appear to be relevant for allogeneic human HSCT
transplantation. However, being a xenograft model, some aspects
of the results should be interpreted with caution. Important
T-cell subsets, such as regulatory T cells (40) and PLZF1+ innate
T cells (41), which are both critical components of immune
competence, do not develop or function properly in NSG mice.
This likely relates to the fact that MHC restriction occurs mostly
on mouse epithelial cells and less frequently on human APC or
via T–T interactions. Thus, clinically significant differences in the
TCR repertoires of T cells selected on mouse thymus versus T
cells that are selected on human thymus exist. Nevertheless, in
experiments where CD34+ cells were transplanted into NSG
mice, a survey of the IgH locus and TCR showed a comparable
combinatorial diversity (42), although the screening method used
in this study (multiplexed PCR of V-J rearrangements) might not
be sensitive enough to detect small differences in TCR reper-
toire between human and xenografted T-cell samples.
Recent work by Rodewald and colleagues proposed cell com-
petition as a mechanism underlying selection for cellular fitness
during T-cell development (43). This hypothesis explains the fur-
ther clonal restriction at DN3, DP, and SP stages that we observe
in many mice. Apparently there is selection for progeny of certain
HSCs clones while others are selected against. Although this could
be merely stochastic (neutral competition), the possibility that
clonal fitness (e.g., metabolic activity, quiescence, other factors)
plays a role is not unlikely given the existence of thymic stem
cell clones with differential gene-expression programs (43). We
therefore propose that the progeny from different HSC clones
have inherently different capacity to pass through various devel-
opmental checkpoints in the thymus. Alternatively, in the experi-
ments where barcoded CD34+ cells were transplanted, we cannot
exclude that in some cases progenitors rather than bona fide HSCs
would be the ancestors of the developing thymocytes. These pro-
genitors are likely to have reduced fitness as well. In the experi-
ments where phenotypically defined HSCs were transplanted, a role
for such progenitors seems much less likely because of the purity of
the transplanted cells. This notion is supported by the fact that in
human gene-therapy settings, a considerable fraction of T-cell may
have arisen from progenitors rather than from HSCs (44).
As a consequence, immune incompetence after HSCT is not
related to the transplantation of limited numbers of HSC but to
intrathymic events. Although transplantation of more HSC may
improve hematological reconstitution, our data suggests it will do
little to improve immunological reconstitution. Thymus seeding is
quickly saturated when the transplanted cell dose increases;
therefore, efforts aimed at improving function of the thymic epi-
thelium (45) rather than increasing the number of transplanted
cells, most likely will be most successful in improving immuno-
logical immune reconstitution after stem cell transplantation.
Materials and Methods
CD34+ and HSC Isolations from UCB. Human CD34+ cells were isolated from
UCB samples. Mononuclear cells of UCB were isolated by Ficoll [Leiden Uni-
versity Medical Center (LUMC) apothecary] density centrifugation, washed,
and stored in liquid nitrogen until further use. Single UCB units (HSCT) or 5 to
10 combined UCB units (CD34+ transplantations) were selected, thawed, and
selected for CD34+ progenitors using the CD34 Microbead Kit (Miltenyi Biotec)
according to the manufacturer’s protocol. Purity of the CD34 selection was
verified by flowcytometry and exceeded 95% purity. HSCs were isolated by
staining with anti-human CD38 (HIT2) PECy7, CD90 (ebio5e10) APC, CD49f
(ebioG0H3) PerCPEfluor710 (all eBioscience), CD34 (8G12) PE, CD45 (HI30)
V450, CD45RA (L48) FITC (BD), and subsequent sorting of CD34+CD38−
CD45RA−CD90+CD49f+ cells using a BD Aria II SORP cell sorter (Beckton-
Dickinson). The cells were subsequently cultured in Stemspan (Stem Cell
Technologies), in the presence of 10 ng/mL stem cell factor (a gift from
Amgen, Thousand Oakes, CA), 20 ng/mL recombinant human thrombopoietin
(R&D Systems), 20 ng/mL recombinant mouse insulin-like growth factor 2
(R&D Systems), 10 ng/mL recombinant human fibroblast growth factor 1
(Peprotech), and penicillin/streptomycin (Lonza) on retronectin-coated plates
(Takara). The cells were incubated for 24 h at 37 °C and 5% (vol/vol) CO2.
Virus Production and Transduction Procedure. Lentiviral vector pTGZ is de-
rivative of pGIPZ (Thermo, Openbiosystems) where the Puromycin-IRES-MCS
site locus (BsrGI-MluI) was replaced first by BsrGI-ClaI-BamHI-MluI adapter, then
a barcode linker was integrated via BsrGI-BamHI sites between tGFP and the
WPRE element, as described previously (13, 14). The barcode sequence, named
B322, was as follows: AGGNNNACNNNGTNNNCGNNNTANNNCANNNTGNNN-
GAC. Viral particles were generated in 293T cells by transfection of pEnv VSVG,
pMD2 GagPol, pREV and the barcoded vector backbone pTGZ-B322. Titers
were determined on isolated CD34+ cells to achieve a transduction efficiency
of 20% to minimize the occurrence of multiple virus integrations per cell,
while maintaining a reasonably high marking rate. UCB CD34+ cells were
cultured as described above at 6,500 cells/cm2 density. After 24 h, the cells
were spinoculated with virus supernatant at a multiplicity of infection = 1,
after which the supernatant was replaced with fresh Stemspan medium
with cytokines. The cells were kept for 16 h at 37 °C and 5% (vol/vol) CO2
and then prepared for transplantation. Because lentiviral vectors cause
pseudotransduction (protein expression from the preintegration complex),
assessment of the transduction rate at the moment of transplantation is not
accurate. Instead, a fraction of transduced cells was kept in culture for an
additional week until the nonintegrated preintegration complexes were di-
luted out and the transduction rate could be determined by flow cytometry.
Animals and Transplantation. NSG mice (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ, NSG)
were obtained from Charles River Laboratories and bred in individually ven-
tilated cages under specific pathogen-free conditions. Mice (aged 5–6 wk)
were sublethally irradiated with 1.91 Gy X-rays using orthovoltage irradiation
and transplanted 24 h after irradiation via tail vein injection with the indicated
cell numbers. Mice were fed Diet Gel recovery (Clear H2O) and kept on anti-
biotics [560 μg/L polymixin B (Bupha), 700 μg/L ciprofloxacin (Bayer), 800 μg/L
amphotheracin B (Bristol-Myers Squibb)] in autoclaved acidified drinking
water until white blood cell counts were recovered at 4 wk posttransplant.
Blood samples were obtained at 4, 8, 12, 16, and 21 wk by lateral tail vein
incision. At 16 or 21 wk, mice were killed by O2/CO2 inhalation and thymus,
BM, PB, and spleen were isolated. BM cell suspensions were made by crushing
the bones in IMDM (Lonza) and passing the remaining cells through a 70-μm
filter. Spleen and thymus were homogenized by passing them through a
70-μm filter.
Flowcytometry. Erythrocytes in the PB samples were lysed using an isotonic
NH4Cl buffer (LUMC apothecary), after which the cells were stained with the



























indicated antibodies in PBS/0.2% BSA /0.1% sodium azide buffer for 30 min
on ice. Cells were subsequently sorted using a FACS Aria II SORP (BD).
Spleen and PB cells were stained using anti-human CD45 (HI30) v450, CD19
(SJ25C1)APCCy7, CD3 (SK7) PE, CD4 (RPA-T4)V500, CD8 (SK1) PECy7, CD13 (WM15)
APC, and CD33 (WM53) APC (all BD). PB cells were sorted into T cells (huCD45+
CD3+) B cells (huCD45+ CD19+) and myeloid cells (huCD45+ CD13+/CD33+) and
splenocytes into B-cell (huCD45+CD19+) and T-cell (huCD45+CD3+) populations.
BM cells were stained using anti-human CD45 (HI30) V450, CD34 (8G12)
PE, (BD), CD38 (HIT2) PECy7, CD90 (ebio5e10) APC, and CD49f(ebioG0H3)
PerCPEf710 (eBioscience). HSC (huCD45+CD34+CD38−CD90+CD49f+) were sorted.
Thymus cells were stained using human CD45 (HI30) V450, CD1a (HI149) APC,
CD34 (8G12) PE, CD3e (UCHT1) PECy5, CD4 (RPA-T4) APCCy7, and CD8 (SK1)
PECy7 (all BD), after which DN1/2 (huCD45+CD3−CD34+CD1a−) and DN3
(huCD45+CD3−CD34+CD1a+), DP (huCD45+CD3+CD4+CD8+), and SP (huCD45+
CD3+CD4+ and huCD45+CD3+CD8+) were sorted.
Spike-in Experiment. Plasmid DNAwith a known barcodewasmixedwith DNA
from polyclonally transduced population of cells at 0%, 1%, 3%, 10%, 30%,
and 100% based on the estimation that one virus was inserted per genome
(3.3 × 109 bp). The size of the plasmid was 10,201 bp and carried one DNA
barcode. The samples were then processed for barcode determination as
described below.
DNA Preparation and Deep Sequencing. DNA from the sorted populations was
extracted using Sigma GenElute columns (Sigma-Aldrich), according to the
manufacturer’s instructions, with the addition of 5-μg herring sperm DNA as
carrier material. The DNA barcode was amplified using LWGFP_pTGZ (CACA-
TGCACTTCAAGAGCGCCAT) and LWPRE_pTGZ (TGAAAGCCATACGGGAAGCA)
primers (Sigma-Aldrich), at 0.6 μM, using GoTaq polymerase (Promega) and a
temperature profile of 95 °C for 5 min, followed by 35 cycles of 95 °C for 30 s,
60° for 30 s, and 72 °C for 30s, with a final extension of product at 72 °C for
10 min. The 379-bp resulting product was cleaned using Qiagen PCR clean-up
columns according to the manufacturer’s instructions (Qiagen). The cleaned
products were then multiplexed by adding an Iontorrent adapter with sample
multiplexing barcodes to one side CCATCTCATCCCTGCGTGTCTCCGACTCAG
[eight base multiplexing barcode] GCAGATGCCGGTGAAGAATAATGTAC and a
common IonTorrent adapter CCTCTCTATGGGCAGTCGGTGATAGTCAATCTTT-
CACAAATTTTGTA to the other side (95 °C for 5 min, followed by 35 cycles of
95 °C for 30 s, 60° for 30 s, and 72 °C for 30s). The resulting 208-bp amplicons
were separated on a 2% (wt/vol) agarose gel, the products were excised and
cleaned using Qiagen gel extraction columns, mixed in equimolar amounts,
and submitted to the LUMC sequencing core facility (Leiden Genome Tech-
nology Center), where library concentration was determined using a High
Sensitivity DNA kit on an Agilent Bioanalyzer (Agilent). The library was am-
plified using emulsion PCR using the Ion PGM Template OT2 200 kit (Agilent)
and subsequently sequenced using the Ion PGM Sequencing 200 Kit v2 (Agilent)
and 314 or 316 chips, according to the manufacturer’s instructions.
Sequence Analysis. FASTQ files were retrieved from the sequencer and un-
derwent overall quality control using FASTQC (Simon Andrews, Babraham
Institute, Cambridge, United Kingdom; available at www.bioinformatics.
babraham.ac.uk/projects/fastqc/), after which the sequences were separated
by sample multiplexing barcode using a custom BioPerl script (www.bioperl.
org/wiki/Main_Page) that uses regular expressions to determine primer
and sample barcode sequences. From the resulting FASTA files, the DNA
barcodes were extracted using a custom BioPerl script that determined
barcode location based on a regular expression matching the surrounding
virus sequences and the invariable doublets within the DNA barcode. Sam-
ples with >100 associated reads were considered for analysis. These barcodes
were clustered using R (R-3.0.0, www.r-project.org) by calculating dissimi-
larity between all barcodes for all samples of an animal. Read numbers for
barcodes with dissimilarity of less than 2 nt were clustered and added
together, thereby correcting for sequencing errors (46). Simulation of ran-
dom sets of 485 barcodes showed that the frequency of 1- to 2-nt distances
would occur in fewer than 1/1,000 reads; therefore, a dissimilarity threshold
of 2 nt seems appropriate to eliminate false barcode reads in sequencing
results caused by PCR and sequencing errors. By applying this strategy to the
sequenced library pool, this resulted in a set of barcodes that agreed with
the expected size of our DNA barcode library (485 barcodes by sequencing
with noise removal, compared with the 500 single bacterial clones that were
selected for the preparation of the vector library). The contribution of each
clone to a particular tissue was normalized by dividing the reads for each
clustered clone by the total number of reads per sample. The resulting
fraction of contribution was then displayed.
TCR Analysis. Rearrangements of TRB, TRG, and TRD loci were analyzed by
means of BIOMED-2 multiplex PCR assays (47) and visualized via GeneScan
analysis. All assays were performed using the proper clonal, polyclonal
and negative controls, and according to the published BIOMED-2 multi-
plex PCR protocol.
Statistics. To describe the population diversity in the thymus, we calculated
the Shannon diversity index using the cell number isolated from a tissue (HSC
or thymus DN1/2, DN3, DP, and SP, or spleen CD3 cells) multiplied by the
fraction of each clone as determined by barcode sequencing (shown in Fig.
3A) for all reads making up more than 1% of the reads recovered in these
tissues. The Shannon indices obtained in this way were then normalized per
animal to allow comparison between animals. Differences in Shannon di-
versity between subsets were analyzed using a Wilcoxon rank sum test,
considering P < 0.05 significant.
Study Approval. Experimental procedures were approved by the Ethical
Committee on Animal Experiments of the Leiden University Medical Center.
The UCB samples used in this study were collected at the Diakonessenhuis
hospital, Leiden, after informed consent was given by the parents. PB control
samples were obtained with informed consent under guidelines issued by the
Medical Ethics Committee of the Leiden University Medical Center (Leiden,
The Netherlands).
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